Cigarette Smoking Status at Diagnosis and Recurrence in Intermediate-risk Non-muscle-invasive Bladder Carcinoma Reply

被引：0
|
作者：
Serretta, Vincenzo [1 ]
机构：
[1] Univ Palermo, Urol Sect, Maternal Infant Androl & Urol Dept, Palermo, Italy
来源：
UROLOGY | 2013年 / 81卷 / 02期
关键词：
CANCER-DIAGNOSIS;
D O I：
10.1016/j.urology.2012.09.043
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：281 / 282
页数：2
相关论文
共 50 条
  • [21] The optimal intravesical maintenance chemotherapy scheme for the intermediate-risk group non-muscle-invasive bladder cancer
    Jian-Xin Chen
    Wen-Ting Huang
    Qing-Yun Zhang
    Cheng-En Deng
    Jue-ling Wei
    Yuan-Liang Xie
    Rui Lin
    Guan-Zheng Feng
    Guang-Lin Yang
    Jun Long
    Hao-Yuan Lu
    Zeng-nan Mo
    BMC Cancer, 23 (1)
  • [22] Recurrence- and progression-free survival in intermediate-risk non-muscle-invasive bladder cancer: the impact of conditional evaluation and subclassification
    Kohada, Yuki
    Hayashi, Tetsutaro
    Hsi, Ryan S.
    Yukihiro, Kazuma
    Sentani, Kazuhiro
    Goto, Keisuke
    Inoue, Shogo
    Ohara, Shinya
    Teishima, Jun
    Kajiwara, Mitsuru
    Nishisaka, Takashi
    Yasui, Wataru
    Black, Peter C.
    Matsubara, Akio
    BJU INTERNATIONAL, 2021, 127 (04) : 473 - 485
  • [23] Prediction of recurrence risk in patients with non-muscle-invasive bladder cancer
    Ahmadi, Niloufar
    Shafee, Hamid
    Moudi, Emaduddin
    ASIAN JOURNAL OF UROLOGY, 2024, 11 (04) : 625 - 632
  • [24] Prediction of recurrence risk in patients with non-muscle-invasive bladder cancer
    Niloufar Ahmadi
    Hamid Shafee
    Emaduddin Moudi
    Asian Journal of Urology, 2024, 11 (04) : 625 - 632
  • [25] Prediction model for recurrence probabilities after intravesical chemotherapy in patients with intermediate-risk non-muscle-invasive bladder cancer, including external validation
    Lammers, Rianne J. M.
    Hendriks, Jan C. M.
    Rodriguez Faba Rodriguez Faba, O.
    Witjes, Wim P. J.
    Palou, Joan
    Witjes, J. Alfred
    WORLD JOURNAL OF UROLOGY, 2016, 34 (02) : 173 - 180
  • [26] Prediction model for recurrence probabilities after intravesical chemotherapy in patients with intermediate-risk non-muscle-invasive bladder cancer, including external validation
    Rianne J. M. Lammers
    Jan C. M. Hendriks
    O. Rodriguez Faba Rodriguez Faba
    Wim P. J. Witjes
    Joan Palou
    J. Alfred Witjes
    World Journal of Urology, 2016, 34 : 173 - 180
  • [27] Intravesical Therapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis of Disease Recurrence
    Laukhtina, Ekaterina
    Abufaraj, Mohammad
    Al-Ani, Abdallah
    Ali, Mustafa Rami
    Mori, Keiichiro
    Moschini, Marco
    Quhal, Fahad
    Motlagh, Reza Sari
    Pradere, Benjamin
    Schuettfort, Victor M.
    Mostafaei, Hadi
    Katayama, Satoshi
    Grossmann, Nico C.
    Fajkovic, Harun
    Soria, Francesco
    Enikeev, Dmitry
    Shariat, Shahrokh F.
    EUROPEAN UROLOGY FOCUS, 2022, 8 (02): : 447 - 456
  • [28] IMPACT OF BLADDER NECK INVOLVEMENT AND POSITIVE URINE CYTOLOGY IN SUBSTRATIFYING INTERMEDIATE-RISK NON-MUSCLE-INVASIVE BLADDER CANCER PATIENTS BASED ON THE PREDICTION OF HIGH-RISK RECURRENCE
    Fukushima, Hiroshi
    Toide, Masahiro
    Fukuda, Shohei
    Moriyama, Shingo
    Yasuda, Yosuke
    Uehara, Sho
    Kijima, Toshiki
    Yoshida, Soichiro
    Yokoyama, Minato
    Ishioka, Junichiro
    Matsuoka, Yoh
    Saito, Kazutaka
    Fujii, Yasuhisa
    JOURNAL OF UROLOGY, 2019, 201 (04): : E626 - E626
  • [29] Evaluation of the efficacy and safety of HIVEC intravesical thermochemotherapy with intermediate-risk and high-risk non-muscle-invasive bladder cancer
    Cimier, A.
    Thach, S.
    Lacroix, B.
    Mariat, C.
    PROGRES EN UROLOGIE, 2023, 33 (05): : 254 - 264
  • [30] Re: Prediction Model for Recurrence Probabilities after Intravesical Chemotherapy in Patients with Intermediate-Risk Non-Muscle-Invasive Bladder Cancer, Including External Validation
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2017, 198 (03): : 482 - 482
12345